Pasithea Therapeutics Acquires Alpha-5 Integrin, LLC
22 juin 2022 08h00 HE
|
Pasithea
- Alpha-5 is a potentially first-in-class monoclonal antibody for the treatment of amyotrophic lateral sclerosis (ALS) and other neurological diseases -- Expands pipeline across Pasithea's core...
New Gadolinium-Free MRI Contrast Agent Advances Safer Patient Care
13 juin 2022 10h00 HE
|
Reveal Pharmaceuticals
CAMBRIDGE, Mass., June 13, 2022 (GLOBE NEWSWIRE) -- Contrast agents used in MRI scans to improve the clarity of imaging for diagnostic accuracy, accumulate in the brain and body of every patient,...
Multiple Sclerosis: Is Therapeutic Angiogenesis a Treatment or Even a Possible Cure?
18 nov. 2020 00h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announced that it will give a Webinar broadcast on its potential breakthrough therapy to...
Telehealth Cognitive Rehabilitation Can Be Effective for Multiple Sclerosis
11 mai 2020 08h00 HE
|
Posit Science
SAN FRANCISCO, May 11, 2020 (GLOBE NEWSWIRE) -- An independent review of the scientific literature found that certain telehealth rehabilitation treatments can be effective in addressing cognitive...
Innodem Neurosciences reçoit un million de dollars de financement afin de donner une voix aux patients privés de la parole
19 févr. 2019 15h49 HE
|
Innodem Neurosciences
MONTRÉAL, 19 févr. 2019 (GLOBE NEWSWIRE) -- Innodem Neurosciences, jeune entreprise issue de l’Institut et hôpital neurologique de Montréal (Le Neuro) de l’Université McGill et membre de...
Innodem Neurosciences Receives 1 Million Dollars in Funding to Give a Voice to Voiceless Patients
19 févr. 2019 15h49 HE
|
Innodem Neurosciences
MONTREAL, Feb. 19, 2019 (GLOBE NEWSWIRE) -- CENTECH’s Innodem Neurosciences, a Montreal-based start-up that spun-out of McGill University’s Montreal Neurological Institute and Hospital (The NEURO)...
Orion Biotechnology acquires patent portfolio for potent CCR5 chemokine antagonist
06 sept. 2018 13h08 HE
|
Orion Biotechnology Canada Ltd
OTTAWA, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that its subsidiary, Orion Biotechnology Switzerland Sàrl, has...
Alectra Utilities invests $8 million in modernizing Barrie’s electricity grid
04 sept. 2018 11h07 HE
|
Alectra Utilities Corporation
BARRIE, Ontario, Sept. 04, 2018 (GLOBE NEWSWIRE) -- As part of ongoing efforts to enhance overall electricity system reliability in Barrie, Alectra Utilities is investing $8 million to modernize the...
New U.S. Patent Allowance Granted to AXIM® Biotechnologies for Extraction and Purification of Delta-9-THC For Use in MedChew RX Clinical Program
19 juin 2018 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, June 19, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the United States...
AXIM Biotech Reaches Preliminary Agreement for Distribution of CanChew and MedChew Products Throughout South Korea
03 avr. 2018 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTCQB:AXIM), a world leader in cannabinoid research and development, today announced that it has...